SEARCH RESULTS FOR:
Jeff Reingold
COO, CONTRACT PHARMACAL CORP (CPC)
"Our ability to obtain knowledge and information about market trends and establish good communication with customers and vendors allows us to react faster and have some type of contingency in place."
Dave Allan
VICE PRESIDENT OF CANADA, KAL TIRE’S MINING TIRE GROUP
"With predictive maintenance tools being able to take all aspects, even seasons, into account, the system also helps clients with forecasting inventory."
Johnson Lai
VICE PRESIDENT, CHEMICAL SPECIALTIES LIMITED (CSL)
"As a toll manufacturer, we find ourselves in a sweet spot because we can offer a speed-to-market solution in our current facility to producers, many of which wish the localization to be done yesterday."
Ganapathy Swamy
MD SINGAPORE AND HEAD OF ONSITE ACCOUNTS, LINDE ASEAN
"Linde is present in both green and blue hydrogen pathways, and we are committed to support Jurong Island players taking concrete steps."
James Withall
CEO, RUPERT RESOURCES
"We started to demonstrate the prospectivity of our land package and in particular the new 4 million oz Ikkari discovery, which has been the main driver for the valuation of the company over the last 18 months."
Chris Frostad
PRESIDENT AND CEO, PUREPOINT URANIUM GROUP
"Now that more funding is available to the uranium sector we can expand our work across our ten 100% owned projects where early discoveries have already been made."
Philippe Hemmerdinger
PRESIDENT, ASSOCIATION OF INDUSTRIAL MINING SUPPLIERS (APRIMIN)
Chile’s Association of Industrial Mining Suppliers (APRIMIN)
Patricio Gutiérrez
CHAIRMAN OF THE BOARD & CEO, GRUPO IDESA
Grupo Idesa provides an overview of its different petrochemical units in Mexico.
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE
"The surge of communication need has increased exponentially as companies recognize the necessity of conveying a differentiated story amid the unprecedented number of financings and IPOs over the last two years."
Lori Hu
MANAGING DIRECTOR, VERTEX VENTURES HC
"The M&A market has been relatively slow over the past year as pharma executives wait on the sidelines for the valuation correction to play out, but I believe that we will see M&A activities increase in this coming year."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
